Differences in penetration-enhancing effect of Azone through excised rabbit, rat, hairless mouse, guinea pig and human skins

International Journal of Pharmaceutics

Volumn 130, Issue 2, 1996, Pages 225-230

  Niazy, Esmail M ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Animal skins; Azone; Dihydroergotamine; Enhancement factor; Human skin; Laurocapram; Penetration enhancer; Percutaneous absorption

Indexed keywords

DIHYDROERGOTAMINE; LAUROCAPRAM; PENETRATION ENHANCING AGENT; PROPYLENE GLYCOL;

ANIMAL TISSUE; ARTICLE; DIFFUSION; GUINEA PIG; HUMAN; HUMAN TISSUE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RABBIT; RAT; SKIN ABSORPTION; SKIN PENETRATION; SPECIES DIFFERENCE;

EID: 0029944428     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/0378-5173(95)04319-5     Document Type: Article

References (24)

1. Adachi, Y., Hosaya, K., Sugibayashi, K. and Morimoto, Y., Duration and reversibility of the penetration-enhancing effect of Azone. Chem. Pharm. Bull., 36 (1988) 3702-3705.
2. Banerjee, P. and Ritschal, W., Transdermal permeation of vasopressin. II. Influence of Azone on in-vitro and in-vivo permeation. Int. J. Pharm., 49 (1989) 199-204.
3. Barry, B., Properties that influence percutaneous absorption. In Swarbrick, J. (Ed.), Dermatological Formulation: Percutaneous Absorption, Dekker, New York, 1983, pp. 127-233.
4. Beastall, J., Hadgraft, J. and Washington, C., Mechanism of action of Azone as percutaneous penetration enhancer: lipid bilayer fluidity and transition temperature effects. Int. J. Pharm., 43 (1988) 207-213.
5. Bronaugh, R., Stewart, R. and Congdon, E., Methods for in vitro percutaneous absorption studies. II. Animal models for human skin. Toxicol. Appl. Pharmacol., 62 (1982) 481-488.
6. Carelli, V., DiColo, G., Nanoripieri, E. and Serafini, M., Bile acids as enhancers of steroid penetration through excised hairless mouse skin. Int. J. Pharm., 89 (1993) 81-89.
7. Catz, P. and Friend, D., Transdermal delivery of levonorgestrel. VIII. Effect of enhancers on rat skin, hairless mouse skin, hairless guinea pig skin and human skin. Int. J. Pharm., 58 (1990) 93-102.
8. Elfbaum, S. and Laden, K., The effect of dimethyl sulphoxide on percutaneous absorption. J. Soc. Cosm. Chem., 19 (1968) 119-127, 163-172, 841-847.
9. Hadgraft, J., Penetration enhancers in percutaneous absorption. Pharm. Int., 5 (1984) 252-254.
10. Hirvonen, J., Rajala, R., Vihervaara. P., Laine, E., Paronen, P. and Urtti, A., Mechanism and reversibility of penetration enhancer in the skin - a DSC study. Eur. J. Pharm. Biopharm., 40 (1994) 81-85.
11. Kim, C., Kim, J., Chi, S. and Shim, C., Effect of fatty acids and urea on the penetration of ketoprofen through rat skin. Int. J. Pharm., 99 (1993) 109-118.
12. Mahjour, M., Mauser, B. and Fawzi, M., Skin permeation enhancement effects of linoleic acid and Azone on narcotic analgesics. Int. J. Pharm. 56 (1989) 1-11.
13. Niazy, E., Molokhia, A. and El-Gorashi, A., Quick and simple determination of dihydroergotamine by high performance liquid chromatography. Anal. Lett., 21 (1988) 1833-1843.
14. Niazy, E., Molokhia, A. and El-Gorashi, A., Effect of Azone and other penetration enhancers on the percutaneous absorption of dihydroergotamine. Int. J. Pharm., 56 (1989) 181-185.
15. Niazy, E., Molokhia, A. and El-Gorashi, A., Effect of vehicle and drug concentration on transdermal delivery of dihydroergotamine using excised animal skin. Drug Dev. Ind. Pharm., 16 (1990) 1697-1715.
16. Niazy, E., Influence of oleic acid and other permeation promoters on transdermal delivery of dihydroergotamine through rabbit skin. Int. J. Pharm., 67 (1991) 97-100.
17. Okamoto, H., Hashida, M. and Sezaki, H., Structure-activity relationship of 1-alkyl or 1-alkenylazacycloalkanone derivatives as percutaneous penetration enhancers. J. Pharm. Sci., 77 (1988) 418-424.
18. Ruland, A., Kreuter, J. and Rytting, J. Transdermal delivery of the tetrapetide hisetal melanotropin [6-9]. I. Effect of various penetration enhancers: in-vitro study across hairless mouse skin. Int. J. Pharm., 101 (1994) 57-61.
19. Shaw, J., Pharmacokinetics of nitroglycerine and clonidine delivered by transdermal route. Am. Heart. J., 108 (1984) 217-222.
20. Stoughton, R., Enhanced percutaneous penetration with 1-do-decylazacycloheptan-2-one. Arch. Dermatol., 118 (1982) 474-477.
21. Stoughton, R. and McClure, W., Azone: a new non-toxic enhancer of cutaneous penetration. Drug Dev. Ind. Pharm., 9 (1983) 725-744.
22. Wellstein, A., Kuppers, H., Pitschner, H. and Palm, D., Transdermal delivery of bupranolol: pharmacodynamics and β-adrenoceptor occupancy. Eur. J. Clin. Pharmacol., 31 (1986) 419-422.
23. Wiechers, J., Drenth, B., Jonkman, J. and deZeeuw, R., Percutaneous absorption, metabolism and elimination of the penetration enhancer Azone in humans after prolonged application under occlusion. Int. J. Pharm., 47 (1988) 43-49.
24. Wotton, P., Mollgaard, B., Hadgraft, J. and Hoelgaard, A., Vehicle effect on topical drug delivery, III. Effect of Azone on the cutaneous permeation of metronidazole and propylene glycol. Int. J. Pharm., 24 (1985) 19-26.